Procurement Summary
Country: Czech Republic
Summary: Dns Lp 2026-024 - Ravulizumab
Deadline: 29 Jul 2026
Posting Date: 10 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144858321
Document Ref. No.: SZ KZAS/045344/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: CZK 23015000
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The subject of the public contract is the provision of continuous supplies of medicinal products with the active ingredient RAVULIZUMAB for the needs of the contracting authority, as a provider of health services (not for the needs of resale/dispensing), including their direct shipment to pharmacies individual spin-off plants of the contracting authority, on the basis of a framework agreement concluded with one selected supplier for a period of 24 months from the conclusion of the framework agreement. Medicinal preparations and medical devices
DBID: 5175 System number: P26V00000228 File number: SZ KZAS/045344/2026 According to the law: No. 134/2016 Coll. Registration number in VVZ: Z2026-012056 Dynamic purchasing system: A dynamic purchasing system for the supply of medicinal products Start date: 07/09/2026 Offer submit by: 29/07/2026 10:00 Estimated value: 23, 015, 000 CZK without VAT
Documents
Tender Notice
d15f3b4b87fb81001553c34e0b9fd1ef.vyzva.k.podani.nabidky.dns.lp.ravulizumab.pdf
a39af4c7c7243265667481cee6485ab7.01.specifikace.a.podklad.pro.zpracovani.cenove.nabidky.ravulizumab.xlsx
0dadf5a233612f15a63d2c384c3a465a.02.ramcova.smlouva.ravulizumab.docx